جست‌وجوی استاد و پژوهشگر

• Radiation Oncology
• Medical Physics
• Adaptive Radiation Therapy
• +۳ مورد دیگر

Melissa Ghafarian serves as a Health Sciences Assistant Clinical Professor in the Department of Radiation Oncology at the University of California Los Angeles (UCLA) School of Medicine. Her academic appointment places her within one of the nation's leading medical research institutions, where she contributes to both clinical practice and academic advancement in radiation oncology. Dr. Ghafarian's research focuses on the intersection of medical imaging and radiation therapy, with particular expertise in adaptive radiation therapy techniques and quality assurance protocols. Her work addresses critical challenges in precision oncology, including the integration of magnetic resonance imaging with radiation delivery systems and the development of robust quality control measures for advanced treatment modalities like VMAT. Her research contributes to improving treatment accuracy while minimizing radiation exposure to healthy tissues. The publication timeline reveals a focused research trajectory in medical physics applications for radiation oncology, with work spanning both foundational quality assurance methodologies and emerging adaptive therapy technologies. Her recent 2025 publication indicates active engagement with cutting-edge MRI-guided radiation therapy developments. Dr. Ghafarian collaborates extensively within the UCLA Radiation Oncology department and with researchers across institutions, as evidenced by her co-authorship network that includes prominent figures in the field such as Trudy Wu, Amar Kishan, Jie Deng, and Danilo Maziero. Her research appears in high-impact journals including the International Journal of Radiation Oncology, Biology, Physics and the Journal of Applied Clinical Medical Physics. Her conceptual research profile derived from publications emphasizes key areas including Intensity-Modulated Radiotherapy, Electronics applications in medical physics, Imaging Phantoms, Computer-Assisted Radiotherapy Planning, and Retrospective Studies methodology. These concepts reflect her dual focus on both technological innovation and rigorous clinical evaluation in radiation oncology.

Ricky R Savjaniمشاهده پروفایل

استادیار

• Radiation Oncology
• Medical Imaging
• Artificial Intelligence in Healthcare
• +۵ مورد دیگر

Ricky R Savjani is an Assistant Professor-in-residence in the Department of Radiation Oncology at the University of California Los Angeles (UCLA), David Geffen School of Medicine. He clinically treats patients with Head & Neck cancers, as well as Brain and Spine metastases. He leads a research laboratory focused on advanced imaging, clinical informatics, and artificial intelligence applications in radiation oncology. Dr. Savjani's research interests span radiation oncology, medical imaging, and artificial intelligence in healthcare. His work focuses on translating neuroimaging advances to capture cancer tissue properties and guide radiotherapy. He has developed innovative frameworks for sharing radiation dose distribution maps in electronic medical records (Push2PACS project published in Radiology: Imaging Cancer) and works with industry partners including Varian and NVIDIA. His research integrates machine learning models into clinical radiation oncology practice, with emphasis on image registration, motion management, and tumor segmentation. His recent publications demonstrate strong trends in applying AI and advanced imaging techniques to radiation oncology challenges, particularly in head and neck cancer, brain metastases, and motion management. The research spans from clinical implementation of novel imaging techniques like 5DCT to developing machine learning models for treatment prediction and optimization. His work bridges the gap between advanced computational techniques and practical clinical applications in radiation therapy. ASTRO-Varian Research Training Fellowship (2020-2021) Trainee Editorial Board of Radiology: Imaging Cancer Dr. Savjani mentors a diverse research team including postdoctoral fellows, graduate students, medical students, and research staff. His lab has developed computational infrastructure with multiple GPU servers (totaling 14 GPUs, 256 CPU cores, 3086 GB RAM, 376 TB storage) to support AI research in radiation oncology. Current projects include functional MRI neuroscience, resting-state fMRI, radiation therapy dose distribution sharing (Push RT 2 PACS), and saccadotopy functional mapping.

• Exercise Gerontology
• Exercise Oncology
• Cancer Rehabilitation
• +۳ مورد دیگر

Professor Dennis Taaffe is a leading academic in Exercise Gerontology and Exercise Oncology at Edith Cowan University (ECU), affiliated with the School of Medical and Health Sciences and the Exercise Medicine Research Institute. He holds a prestigious Vice-Chancellor’s Professorial Research Fellowship. His academic journey includes a PhD from the University of Oregon, postdoctoral training at Stanford University, and additional qualifications such as a DSc from Charles Sturt University and an MPH in epidemiology from the University of Hawai'i. Professor Taaffe’s research focuses on the intersection of exercise, aging, and cancer, with a particular emphasis on improving treatment outcomes through exercise interventions. His work spans clinical trials, systematic reviews, and meta-analyses examining the effects of exercise on muscle function, inflammation, and cancer progression. Notable contributions include studies on exercise’s role in mitigating side effects of androgen deprivation therapy for prostate cancer and its impact on tumor biology. Key achievements include awards for clinical research excellence and teaching, along with recognition from the American College of Sports Medicine and Exercise and Sports Science Australia. His research has been published in high-impact journals such as JAMA Network Open , Journal of the National Cancer Institute , and British Journal of Sports Medicine . Professor Taaffe leads the Exercise and Gastrointestinal Cancers Research Group and collaborates on national and international projects, including clinical trials like the ERADICATE study (examining exercise and radiation therapy efficacy) and the EXPAN trial (focusing on pancreatic cancer prehabilitation). His work bridges clinical practice and research, aiming to integrate exercise as a cornerstone of cancer care.

• Healthcare Innovation
• Vulnerable Populations Care
• Medical Informatics
• +۴ مورد دیگر

Dr. David Rosenthal is an Assistant Professor of Medicine (General Internal Medicine) at Yale School of Medicine. He is affiliated with the Errera Community Care Center and serves as a Healthcare Venture Partner at AlleyCorp. His clinical and research focus includes care for vulnerable populations, particularly veterans experiencing homelessness, and innovative healthcare technologies such as mobile applications for buprenorphine treatment. Dr. Rosenthal has held leadership roles in the Homeless Patient Aligned Care Team (HPACT) and contributed to national initiatives addressing veteran homelessness. Education: B.A. in Visual and Environmental Studies from Harvard University (2001) M.D. from Northwestern University Feinberg School of Medicine (2008) Medical residency at Brigham and Women's Hospital (2012) Research Interests: Dr. Rosenthal's work bridges clinical care innovation and healthcare equity, with a focus on: Technology-driven solutions for underserved populations Medical-legal partnerships and policy advocacy Radiation oncology advancements for head/neck cancers His research has led to impactful programs like the VA HPACT model and the Buprenorphine Home Induction Mobile App. Professional Contributions: He holds advisory roles with AlleyCorp, 4Catalyzer, and the New Haven Regional Biosciences Collaborative. His leadership in medical education includes co-directing Yale's Professional Responsibility and Introduction to the Profession courses. Awards: Aspen Institute Health Innovators Fellowship (2022) Proclamation from New Haven Mayor for pandemic response (2020) Roivant Science Prize (2018) Labs/Teams: Co-director of the Yale CBIT (Center for Biomedical Innovation and Technology) and member of the Errera Community Care Center leadership team.

Yue Yanمشاهده پروفایل

استادیار مدعو

• MRI-guided radiation therapy
• Machine Learning in Radiation Therapy
• Personalized Radiation Therapy
• +۳ مورد دیگر

Yue Yan holds dual roles as Adjunct Assistant Professor of Engineering at Thayer School of Engineering and Assistant Professor of Radiation Oncology and Applied Sciences at Geisel School of Medicine, Dartmouth College. His expertise bridges medical physics and engineering, focusing on advancing radiation therapy techniques through innovative technologies. Education: BS in Sciences & Technology of Electronic Information, Xiamen University (2005) DSc in Theoretical Physics, Institute of Physics, Chinese Academy of Sciences (2010) PhD in Medical Physics, University of Wisconsin-Madison School of Medicine (2015) Research Interests: Dr. Yan’s work centers on improving radiation therapy precision through MRI-guided systems, machine learning applications, and personalized treatment planning. He investigates geometric distortion impacts in MRI imaging and explores novel dosimetric methodologies. Patents: System and method for control of external beam radiation (Patent #9486646)

Florien Boeleمشاهده پروفایل

دانشیار

• Medical Psychology
• Neuropsychology
• Family Caregiving
• +۱۳ مورد دیگر

Dr. Florien Boele is an Associate Professor of Medical Psychology at the School of Medicine, University of Leeds, Faculty of Medicine and Health. She is supported by a Yorkshire Cancer Research University Academic Fellowship and holds dual affiliations with the Leeds Institute of Medical Research (LIMR) Patient Centred Outcomes Group and the Academic Unit of Health Economics within the Leeds Institute of Health Sciences (LIHS). Her research is centered on improving supportive and palliative care for neuro-oncology patients and their families, with a particular focus on vulnerable populations. PhD in Medical Psychology, VU University Amsterdam (2015) MSc in Clinical Neuropsychology BSc in Psychology Her research interests span family caregiving , quality of life , patient-reported outcomes (PROs) , and symptom management in brain tumour populations, including glioma and meningioma. She investigates disparities in access to support, develops and validates PRO instruments (e.g., EORTC IADL-BN32), and evaluates digital and psychosocial interventions for caregivers. Her work integrates both qualitative and quantitative methods, with strong emphasis on long-term survivorship and equity in care. Analysis of her recent publications (2021–2025) reveals a consistent focus on caregiver burden, longitudinal quality of life, rehabilitation, and methodological rigor in neuro-oncology trials. She leads and contributes to international initiatives such as RANO-Cares and EORTC, setting standards for PRO reporting and cognitive health assessment. Her work increasingly explores digital health tools (e.g., OurBrainBank) and personalized support systems. Scientific awards and recognitions include: Yorkshire Cancer Research University Academic Fellowship Niels Stensen Fellowship She is actively involved in research leadership, serving as Associate Editor for Neuro-Oncology Practice and contributing to EANO’s Scientific and Disparity Committees. She supervises PhD and DClin students and teaches on the MBChB and iBSc Medical Education programs. Her collaborative work includes major trials such as APPROACH, ARISTOCRAT, and BE SPeCiaL, reflecting a strong grant and project leadership profile. She is embedded in key research groups including the Brain Cancer Research Group and the Patient Centred Outcomes team, driving interdisciplinary, patient-focused research.

Roger Jonesمشاهده پروفایل

استاد

• Particle Accelerator Physics
• Beam Dynamics
• Wake-field Analysis
• +۷ مورد دیگر

Roger Jones is a Professor of Particle Accelerator Physics at the University of Manchester, leading the Accelerator Physics Group with strong affiliations to the Cockcroft Institute of Accelerator Science and Technology. Previously serving as Head of the Particle Accelerator Physics Group and Head of Education, Training and Outreach at the Cockcroft Institute, he maintains active international collaborations with CERN, DESY, SLAC, and other major accelerator facilities worldwide. His research focuses on beam dynamics, wake-field analysis, and VHEE (Very High Energy Electron) FLASH radiotherapy . Key areas include collective effects in particle accelerators, beam impedance issues for LHC and CLIC, and the development of novel accelerator applications in medical physics. His work spans both theoretical and experimental aspects, with particular emphasis on understanding large-scale colliders and compact medical accelerators. Analysis of his recent publications reveals a strong trend toward medical applications of accelerator physics, particularly in FLASH radiotherapy research. His work bridges fundamental accelerator science with practical oncology applications, showing increasing collaboration between physics and medical research teams. The publications demonstrate expertise in beam dynamics, radiation biology, and treatment planning optimization. Fellow of the Institute of Physics (FInstP) Chartered Scientist (CSci) Chartered Physicist (CPhys) Fellow of the Royal Society of Arts (FRSA) Fellow of the Higher Education Academy (FHEA) Senior Member of IEEE (SMIEEE) Professor Jones actively supervises PhD students (23 supervised works documented) and teaches graduate-level courses on linear accelerators and wakefields. His research is supported through international collaborations including the Cockcroft Institute project (2017-2018) and ongoing work with CERN, DESY, and SLAC. Current PhD opportunities focus on VHEE radiotherapy machine design, dose studies, and wakefield analysis for XFELs, with some projects requiring extended periods at CERN. His research group operates within the Manchester Accelerator Physics Group and the Cockcroft Institute, utilizing internationally acclaimed particle accelerators for postgraduate studies and research. The group maintains specialized facilities for studying beam dynamics, wake-fields, and photocathode science, with strong connections to the CLEAR facility at CERN for FLASH radiotherapy experiments.

• Neurological Rehabilitation
• Spasticity
• Botulinum Toxin Therapy
• +۴ مورد دیگر

Professor Michael Barnes is a distinguished researcher at Newcastle University specializing in neurological rehabilitation, with over two decades of contributions to spasticity management and botulinum toxin therapy. His work bridges clinical practice and biomechanical research, focusing on evidence-based interventions for stroke, multiple sclerosis, and movement disorders. His primary research domains include: Spasticity Measurement : Pioneering objective assessment tools beyond the Modified Ashworth Scale Botulinum Toxin Applications : Optimizing dosing, efficacy, and resistance management Stroke Rehabilitation : Leading the landmark BoTULS trial for upper limb recovery Guideline Development : Shaping EFNS protocols for dystonia and post-polio syndrome Analysis of his 2001-2022 publications reveals evolving expertise from biomechanical spasticity characterization (2001-2003) to large-scale clinical trials (2006-2012), with recent expansion into autoimmune comorbidities (2022). His work consistently emphasizes clinically meaningful outcomes over isolated impairment metrics. Professor Barnes has directed major NIHR-funded projects including the BoTULS trial and contributed to European task forces establishing diagnostic standards. His collaborations with Newcastle colleagues like Dr. Anand Pandyan and Dr. Lisa Shaw demonstrate sustained institutional research leadership. He has significantly influenced community rehabilitation models, co-authoring foundational work on MS team development and rural disability services, demonstrating commitment to translating research into real-world healthcare systems.

Fatih Demircioğluمشاهده پروفایل

دانشیار

• Radiation Oncology
• Breast Cancer
• Central Nervous System Tumors
• +۳ مورد دیگر

Assoc. Prof. Dr. Fatih Demircioğlu is a faculty member in the Radiation Oncology Department at Istanbul Okan University Hospital, where he has been serving since July 2023. Previously, he worked at Kartal Dr. Lütfi Kırdar Training and Research Hospital (2013-2023) and Rize Training and Research Hospital (2010-2013). He completed his medical degree at Ondokuz Mayıs University (1998-2005) and specialized in Radiation Oncology at Gazi University (2005-2010), becoming an Associate Professor in 2021. His research focuses on: Breast Cancer : Radiotherapy techniques and toxicity management Central Nervous System Tumors : Stereotactic radiotherapy and salvage treatments Lung & Head-Neck Cancers : Re-irradiation strategies and outcome optimization Prostate Cancer : Precision radiotherapy approaches Radiation Safety : Dosimetric evaluations and staff protection protocols His 15 most recent publications (2023-2014) demonstrate strong focus on radiotherapy outcomes across multiple cancer types, with consistent themes in: Advanced techniques like IMRT, stereotactic radiosurgery, and CyberKnife Organ-sparing approaches (e.g., carotid preservation in laryngeal cancer) Palliative care integration for metastatic disease Imaging-guided radiotherapy planning (MRI applications) Treatment toxicity mitigation strategies He has taught graduate courses including Radiation Oncology Basic Principles and Central Nervous System Tumors Radiotherapy . His editorial contributions include peer review for oncology journals, and he holds certifications in radiotherapy physics, clinical research ethics, and stereotactic techniques from institutions like TROD and ESMO.

• Clinical Trial Development
• Prognostic Markers
• Radiation Sensitizers
• +۵ مورد دیگر

David K. Gaffney is a Professor in the Department of Radiation Oncology at the University of Utah and serves as Senior Director for Clinical Research at the Huntsman Cancer Institute . He holds the J Robert and Ann K Stewart Endowed Professorship and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphomas. Education: PhD in Biochemistry (1990), MD (1992) - Medical College of Wisconsin Residency - University of Utah School of Medicine Internship - LDS Hospital, Salt Lake City Dr. Gaffney’s research focuses on clinical trial development , prognostic markers , radiation sensitizers , and secondary cancers . His work addresses improving survival and quality of life for cancer patients through optimized radiation protocols and global health initiatives. Recent publications emphasize brachytherapy for cervical cancer, IMRT applications, and financial implications of treatment regimens. He chairs the Clinical Research Executive Committee at Huntsman Cancer Institute and contributes as a Senior Editor for journals like International Journal of Gynecologic Cancer . Dr. Gaffney actively collaborates with international organizations such as the Gynecologic Cancer Intergroup and has led guidelines for cervical and endometrial cancer staging and treatment.

Ann C. Raldowمشاهده پروفایل

دانشیار

• Radiation Oncology
• Gastrointestinal Cancer
• Hematologic Malignancies
• +۵ مورد دیگر

Ann C. Raldow is an Associate Professor in the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. She specializes in treating gastrointestinal and hematologic malignancies using advanced radiation techniques like IMRT, MRgRT, and SBRT. Princeton University (BA in Molecular Biology) Yale University School of Medicine (MD) Harvard T.H. Chan School of Public Health (MPH) Her research focuses on therapeutic decision-making, cost-effective care, and quality-of-life assessment in cancer treatment. Recent publications emphasize stereotactic radiation applications, health economics, and multidisciplinary approaches to GI and prostate cancers. Super Doctors® Southern California Rising Stars (2019-2024) Top Doctors, Los Angeles Magazine (2021) Dr. Raldow is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. She is board-certified in Radiation Oncology (American Board of Radiology, 2017) and contributes to clinical trials involving rectal and pancreatic cancer treatments.

• Radiation Oncology
• Head and Neck Cancer
• Carbon Ion Therapy
• +۵ مورد دیگر

Dr. T. Held is an active researcher and faculty member in the Department of Radiation Oncology at Heidelberg University's Faculty of Medicine. With numerous publications spanning 2022-2025, Dr. Held has established expertise in advanced radiotherapy techniques, particularly focusing on head and neck cancer treatment. Dr. Held's research interests center on radiation oncology with specialization in head and neck cancer, carbon ion therapy, particle radiotherapy, and radiotherapy dosimetry . Their work investigates innovative approaches to minimize complications while maximizing treatment efficacy, with a particular focus on tissue retraction devices, re-irradiation techniques, and oral complications following radiotherapy. Analysis of recent publications reveals a strong emphasis on clinical trials and translational research in radiation oncology, with significant contributions to understanding optimal treatment approaches for head and neck cancers, meningiomas, and other complex malignancies. The research demonstrates expertise in both photon and particle-based radiotherapy modalities. Dr. Held actively collaborates with researchers across the Heidelberg University Hospital and German Cancer Research Center, contributing to multidisciplinary approaches to cancer treatment. Their work appears in high-impact journals including Radiation Oncology , Head & Neck , and Cancers .

• Medical Physics
• Radiation Oncology
• Magnetic Resonance Imaging
• +۵ مورد دیگر

Chet Ford, Ph.D., serves as Clinical Associate Professor in the Department of Radiation Oncology at the University of Miami, where he integrates clinical medical physics practice with translational research in MRI-guided radiation therapy. Board-certified by the American Board of Radiology in Therapeutic Radiological Physics, his expertise bridges nuclear magnetic resonance physics, clinical oncology, and medical imaging innovation. His educational foundation includes: PhD in Physics, University of Connecticut (1988) MS in Physics, University of Connecticut (1983) BS in Physics, Virginia Commonwealth University (1981) MBA, Drexel University (2003) Postdoctoral training at the University of Pennsylvania (1990) and Virginia Commonwealth University (2010) established his specialization in MRI physics and clinical radiation oncology. His research pioneers the application of quantitative MRI to model tumor physiology and predict radiation response, leveraging daily imaging from hybrid MRI/radiotherapy systems like ViewRay. Current projects focus on machine learning-driven radiomic analysis of prostate cancer and glioblastoma evolution during treatment, with emphasis on adaptive therapy optimization. Recent publications (2023-2025) reveal a cohesive trajectory in exploiting low-field MR-LINAC technology for real-time treatment adaptation. Key themes include radiomic feature stability assessment, deep learning segmentation for tumor tracking, and multi-parametric MRI analysis to decode treatment resistance mechanisms—primarily in prostate cancer and glioblastoma contexts. Award highlights include: NIH Shannon Award Association of University Radiologists Stauffer Award Doctoral Dissertation Fellowship Award Sigma Pi Sigma Physics Honor Society recognition Dr. Ford mentors physics residents, a biomedical engineering graduate student, and postdoctoral researchers in MRI device development. His grant portfolio features an NIH Shared Instrumentation Grant as Principal Investigator and EPA funding for an MR-based water monitoring device, demonstrating cross-disciplinary innovation. Laboratory efforts center on building small-animal MRI platforms and establishing clinical data registries for ViewRay treatment optimization.

Gregory R. Vlacichمشاهده پروفایل

دانشیار

• Lung Cancer
• Esophageal Cancer
• Prostate Cancer
• +۷ مورد دیگر

Gregory R. Vlacich, MD, PhD is an Associate Professor of Radiation Oncology at Washington University School of Medicine in St. Louis. He serves as Vice Chair of Clinical Operations, Clinical Director of Satellite Operations, and Medical Director of Radiation Oncology at Alton Memorial Hospital. Board certified by the American Board of Radiology in Radiation Oncology (2016), Dr. Vlacich specializes in treating multiple cancer types using advanced radiation therapy techniques. His educational background includes: BS in Molecular Biophysics and Biochemistry from Yale University (1999) PhD in Molecular Genetics and Cell Biology from University of Chicago, Pritzker School of Medicine (2007) MD from University of Chicago, Pritzker School of Medicine (2009) Internship at St. Vincent's Catholic Medical Center, New York (2010) Residency in Radiation Oncology at Vanderbilt University Medical Center (2014) Dr. Vlacich's research focuses on improving cancer treatment outcomes through innovative radiation therapy approaches. His work spans thoracic, gastrointestinal, genitourinary, and head and neck oncology, with particular emphasis on stereotactic body radiation therapy and adaptive radiation therapy. He investigates treatment-related toxicity patterns and develops strategies to optimize radiation delivery for various malignancies, especially in elderly patients. His laboratory and clinical work bridges molecular biology insights with practical clinical applications to enhance cancer treatment precision. His publication record shows a progression from foundational molecular biology research to clinical radiation oncology applications. Recent work emphasizes MR-guided radiotherapy, adaptive radiation therapy techniques, and biomarker development for risk stratification. This research trajectory demonstrates how basic science insights translate to improved clinical outcomes for cancer patients. Professional recognition includes: RSNA Roentgen Resident/Fellow Research Award (2014) Board Certification by the American Board of Radiology in Radiation Oncology (2016) Dr. Vlacich maintains an active clinical practice treating various cancers while leading research initiatives through the Siteman Cancer Center and Institute of Clinical and Translational Sciences. His work bridges basic science insights with clinical applications to improve cancer treatment outcomes and patient quality of life. He directs radiation oncology services at Alton Memorial Hospital and is involved in multiple collaborative research projects focusing on improving radiation therapy techniques, understanding treatment toxicities, and developing personalized treatment approaches for cancer patients.

Edvard Abelمشاهده پروفایل

پژوهشگر

• Radiation Oncology
• Cancer Treatment
• Quality of Life in Cancer Patients
• +۳ مورد دیگر

Edvard Abel is affiliated with the Department of Oncology at the University of Gothenburg, where he conducts research focused on radiation oncology and quality-of-life outcomes in cancer patients. He defended his doctoral thesis in oncology in 2022, titled *"Effects on quality of life of new radiotherapy techniques in treatment of head and neck cancer"*. His work emphasizes improving patient outcomes through advanced radiotherapy techniques, precision medicine, and clinical trial design. Dr. Abel's research interests include genomics-guided therapy, neurological effects of radiotherapy, and optimizing patient care through interdisciplinary collaboration. His publications span topics such as biomarker-driven clinical trials (MEGALiT trial), international precision medicine initiatives (PCM4EU/PRIME-ROSE), and longitudinal studies on long-term quality of life in head and neck cancer survivors. His research has been published in journals like *Acta Oncologica*, *Advances in Radiation Oncology*, and *Journal of Clinical Oncology*. While no specific awards are listed, his contributions highlight advancements in oncology treatment protocols and patient-centered care. Dr. Abel collaborates with Sahlgrenska University Hospital and contributes to clinical research teams focused on oncology innovation. His work underscores a commitment to bridging translational research with clinical practice to enhance cancer treatment efficacy and patient well-being.